---
$id: https://graph.org.ai/products/commodity/51101906
$type: Product
source: UNSPSC
code: "51101906"
title: "Proguanil"
class: "51101900"
classTitle: "Antiprotozoals"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Proguanil

**UNSPSC Code**: 51101906
**Class**: [Antiprotozoals](Antiprotozoals.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dihydrofolate reductase inhibitor and antimalarial agent with the molecular formula C11H16ClN5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S61K3P7B2V, chemically known as sn 12,837 but generally known as chlorguanide, which bears US NIH Compound Identifier 6178111. European Medicines Agency schedules Proguanil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10079MIG. The term PROGUANIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules chlorguanide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule proguanil under HS 29252900 and SITC 51482. As of Q4 2014, PROGUANIL remains the US FDA Preferred Term for this commodity. Proguanil bears US NLM identifiers UMLS ID C0008241 and NCI Concept Code C61907. SMILES: CC(C)N=C(N)/N=C(\N)/NC1=CC=C(C=C1)CL.

